Bristol Myers Squibb

BMY · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.579%

12M weight contribution

+0.177 pp

3M weight contribution

+0.064 pp

12M price return

+54.3%

Share of matched S&P 500 members

Monthly observations through Nov 2022

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Nov 2022	$170.7bn	0.579%	+0.177 pp	+54.3%	Yes
Oct 2022	$164.7bn	0.585%	+0.152 pp	+36.8%	Yes
Sep 2022	$151.8bn	0.597%	+0.135 pp	+22.9%	Yes
Aug 2022	$143.9bn	0.515%	+0.018 pp	+4.0%	No
Jul 2022	$157.5bn	0.541%	+0.024 pp	+12.1%	No
Jun 2022	$163.9bn	0.638%	+0.111 pp	+19.8%	Yes
May 2022	$160.6bn	0.579%	+0.053 pp	+18.5%	Yes
Apr 2022	$160.3bn	0.579%	+0.074 pp	+24.5%	Yes
Mar 2022	$159.2bn	0.536%	+0.259 pp	+19.4%	Yes
Feb 2022	$149.7bn	0.519%	+0.245 pp	+15.6%	Yes
Jan 2022	$144.0bn	0.484%	+0.152 pp	+9.1%	Yes
Dec 2021	$138.4bn	0.443%	-0.124 pp	+2.9%	No
Nov 2021	$119.0bn	0.402%	-0.197 pp	-11.3%	No
Oct 2021	$129.6bn	0.433%	-0.191 pp	+3.1%	No
Sep 2021	$131.5bn	0.462%	+0.461 pp	+2.0%	No
Aug 2021	$148.6bn	0.497%	+0.496 pp	+10.8%	Yes
Jul 2021	$150.8bn	0.517%	+0.516 pp	+19.3%	Yes
Jun 2021	$149.2bn	0.527%	+0.526 pp	+17.2%	Yes
May 2021	$146.7bn	0.526%	+0.525 pp	+13.5%	Yes
Apr 2021	$139.4bn	0.505%	-0.263 pp	+5.9%	Yes
Mar 2021	$141.4bn	0.277%	+0.276 pp	+17.8%	No
Feb 2021	$137.4bn	0.275%	+0.274 pp	+7.1%	No
Jan 2021	$138.8bn	0.332%	-0.174 pp	+0.7%	No
Dec 2020	$140.2bn	0.567%	+0.054 pp	+0.4%	Yes

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.